enetic risk scores (GRSs) quantify an individual's risk for a specified condition using estimates derived from genome-wide association studies. Early studies evaluating the use of cardiovascular disease GRSs comprising known coronary heart disease (CHD) risk variants demonstrate that high GRSs are associated with increased risk for cardiovascular events.
<0.2). The GRS for each participant was calculated using the allele count at each variant identified multiplied by the beta from the published genome-wide association studies for that variant. The products of the allele count and β were summed over all 46-loci for the total GRS and divided by average effect size (the average of betas from all published SNPs included in our GRS analysis). The data, analytic methods, and study material have been made available to other researchers for purposes of reproducing the results in this correspondence, and MESA genotyping data can be accessed via dbGaP. No Institutional Review Board approval was required for this study.
Because the vast majority of genome-wide association studies for CHD were among white participants, this initial analysis focused on the white subpopulation of MESA. We excluded one participant because of incomplete genotyping data, so our final analysis included 2526 white participants. Sex differences were not apparent for age or mean GRS (all P>0.1). The rate of incident CHD in males was almost twice the rate in females. Mean GRS did not differ between males and females ( Figure) .
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October 2018 A 46-SNP CHD GRS was significantly associated with CHD event rate in white males. For incident CHD, we found that GRS was strongly correlated with an increased risk for incident CHD in men. Male participants in the highest risk quartile of GRS were at a 1.92× (95% CI, 1.19-3.11) increased risk for incident CHD than participants in the lowest GRS category. This finding was statistically significant based on a generalized linear model to test trend (P=0.022). In women, there was no statistically significant association or trend exhibited (P=0.296; Figure) . Restricted cubic splinebased dose-response curves were used to further demonstrate the presence of a relationship in disease risk (hazard ratio) and GRS for males and the absence of this relationship in females (Figure) . Indeed, the association between the GRS and events differed significantly between men and women.
Our findings, with respect to white men, are consistent with existing studies which have shown that a CHD GRS comprised established CHD risk variants predict risk for incident CHD events. [1] [2] [3] However, this finding was not demonstrated among women in the MESA cohort. This suggests that some of the known CHD risk SNPs may only be predictive of risk in white men and not in white women. Discovery studies in women alone or analyses stratified on sex are necessary to identify female-specific risk variants. Female-specific risk variants could lead to a female-specific GRS. More importantly, however, it could identify targets for study to better understand the pathophysiology of heart disease in women.
The greatest limitation of our study is its modest sample size. Our finding needs to be tested in a larger sample size, with greater female CHD events. Furthermore, although we worked to curate the best list of SNPs, our list is not exhaustive as there will certainly be more discovered in future studies. Nevertheless, the observation that in MESA whites, the association between GRS and events differed significantly between men and women supports the concept that at a genome level, CHD in women may have a different set of risk SNPs. PMID 24316577, 23202125, 26343387, 17478679, 17634449, 19198612, 21088011, 21239051, 21378986, 21378988, 21673312, 21606135, and 22751097 . B. Summary white MESA (Multi-Ethnic Study of Atherosclerosis) participant statistics. Incident CHD events include myocardial infarction (MI), CHD death, definite or probably angina and resuscitated cardiac arrest. C, CHD event rates and hazard ratios. P values determined using a generalized linear model (GLM). D, Restricted cubic spline-based dose-response curves for male and female. BMI indicates body mass index; and GRS, genetic risk score.
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